{
"info": {
"nct_id": "NCT05099562",
"official_title": "Precision Acupuncture in the Treatment of Peripheral Neuropathy After Taxanes Chemotherapy in Breast Cancer",
"inclusion_criteria": "1. The patient was at least 18 years old and had reported grade 1 or higher neuropathic symptoms for more than 2 weeks;\n2. Patients were screened for eligibility by the investigator prior to enrollment, including verification of baseline neuropathic symptoms.\n3. Patients had a diagnosis of stage I, II, or IIIA breast cancer;\n4. Have completed at least 2 weeks of chemotherapy;\n5. Higher scores indicate more severe symptoms;\n6. Voluntarily participate in the clinical trial and sign the informed consent form after informed consent (patients voluntarily accept the treatment and give informed consent);\n7. Eastern Cooperative Oncology Group (ECOG ) score of physical condition (0-1);\n8. Patients with previous local recurrence were eligible;\n9. The basic indexes were consistent, and the blood routine and ECG were normal.\nHealthy volunteers allowed\nMust be FEMALE\nMust have minimum age of 18 Years\nMust have maximum age of 75 Years",
"exclusion_criteria": "1. patients with needle phobia;\n2. Low platelet count (<50 000); co-morbidity with a bleeding disorder; comorbidity with thyroid dysfunction; pregnancy; haemoglobin levels <10 g/dl and haematocrit <30; anaemia on active pharmacological treatment or receiving blood transfusion or steroids;\n3. having metastatic or recurrent disease, history of preexisting peripheral neuropa- thy prior to chemotherapy, uncontrolled seizure disorder, unstable cardiac disease or myocardial infarction within 6 months prior to study entry;\n4. Being pregnant or nursing, or having used acupuncture for peripheral neuropathy within 6 months prior to study entry;\n5. Life expectancy <6 months;\n6. Lymphedema of limbs;",
"miscellaneous_criteria": ""
},
"inclusion_lines": [
{
"line": "1. The patient was at least 18 years old and had reported grade 1 or higher neuropathic symptoms for more than 2 weeks;",
"criterions": [
{
"exact_snippets": "at least 18 years old",
"criterion": "age",
"requirements": [
{
"requirement_type": "N/A",
"expected_value": {
"operator": ">=",
"value": 18,
"unit": "years"
}
}
]
},
{
"exact_snippets": "reported grade 1 or higher neuropathic symptoms",
"criterion": "neuropathic symptoms",
"requirements": [
{
"requirement_type": "severity",
"expected_value": {
"operator": ">=",
"value": 1,
"unit": "grade"
}
}
]
},
{
"exact_snippets": "neuropathic symptoms for more than 2 weeks",
"criterion": "duration of neuropathic symptoms",
"requirements": [
{
"requirement_type": "duration",
"expected_value": {
"operator": ">",
"value": 2,
"unit": "weeks"
}
}
]
}
]
},
{
"line": "2. Patients were screened for eligibility by the investigator prior to enrollment, including verification of baseline neuropathic symptoms.",
"criterions": [
{
"exact_snippets": "verification of baseline neuropathic symptoms",
"criterion": "neuropathic symptoms",
"requirements": [
{
"requirement_type": "presence",
"expected_value": true
}
]
}
]
},
{
"line": "3. Patients had a diagnosis of stage I, II, or IIIA breast cancer;",
"criterions": [
{
"exact_snippets": "diagnosis of stage I, II, or IIIA breast cancer",
"criterion": "breast cancer",
"requirements": [
{
"requirement_type": "stage",
"expected_value": [
"I",
"II",
"IIIA"
]
}
]
}
]
},
{
"line": "4. Have completed at least 2 weeks of chemotherapy;",
"criterions": [
{
"exact_snippets": "completed at least 2 weeks of chemotherapy",
"criterion": "chemotherapy",
"requirements": [
{
"requirement_type": "completion",
"expected_value": {
"operator": ">=",
"value": 2,
"unit": "weeks"
}
}
]
}
]
},
{
"line": "5. Higher scores indicate more severe symptoms;",
"criterions": [
{
"exact_snippets": "Higher scores indicate more severe symptoms",
"criterion": "symptom severity",
"requirements": [
{
"requirement_type": "severity",
"expected_value": "higher scores"
}
]
}
]
},
{
"line": "6. Voluntarily participate in the clinical trial and sign the informed consent form after informed consent (patients voluntarily accept the treatment and give informed consent);",
"criterions": [
{
"exact_snippets": "Voluntarily participate in the clinical trial",
"criterion": "voluntary participation",
"requirements": [
{
"requirement_type": "presence",
"expected_value": true
}
]
},
{
"exact_snippets": "sign the informed consent form",
"criterion": "informed consent form",
"requirements": [
{
"requirement_type": "signed",
"expected_value": true
}
]
}
]
},
{
"line": "7. Eastern Cooperative Oncology Group (ECOG ) score of physical condition (0-1);",
"criterions": [
{
"exact_snippets": "Eastern Cooperative Oncology Group (ECOG ) score of physical condition (0-1)",
"criterion": "ECOG score",
"requirements": [
{
"requirement_type": "range",
"expected_value": {
"comparisons": [
{
"operator": ">=",
"value": 0,
"unit": "N/A"
},
{
"operator": "<=",
"value": 1,
"unit": "N/A"
}
]
}
}
]
}
]
},
{
"line": "8. Patients with previous local recurrence were eligible;",
"criterions": [
{
"exact_snippets": "Patients with previous local recurrence",
"criterion": "previous local recurrence",
"requirements": [
{
"requirement_type": "presence",
"expected_value": true
}
]
}
]
},
{
"line": "9. The basic indexes were consistent, and the blood routine and ECG were normal.",
"criterions": [
{
"exact_snippets": "basic indexes were consistent",
"criterion": "basic indexes",
"requirements": [
{
"requirement_type": "consistency",
"expected_value": true
}
]
},
{
"exact_snippets": "blood routine ... normal",
"criterion": "blood routine",
"requirements": [
{
"requirement_type": "status",
"expected_value": "normal"
}
]
},
{
"exact_snippets": "ECG ... normal",
"criterion": "ECG",
"requirements": [
{
"requirement_type": "status",
"expected_value": "normal"
}
]
}
]
},
{
"line": "Healthy volunteers allowed",
"criterions": [
{
"exact_snippets": "Healthy volunteers allowed",
"criterion": "volunteer health status",
"requirements": [
{
"requirement_type": "status",
"expected_value": "healthy"
}
]
}
]
},
{
"line": "Must be FEMALE",
"criterions": [
{
"exact_snippets": "Must be FEMALE",
"criterion": "gender",
"requirements": [
{
"requirement_type": "expected_value",
"expected_value": "female"
}
]
}
]
},
{
"line": "Must have minimum age of 18 Years",
"criterions": [
{
"exact_snippets": "minimum age of 18 Years",
"criterion": "age",
"requirements": [
{
"requirement_type": "minimum",
"expected_value": {
"operator": ">=",
"value": 18,
"unit": "Years"
}
}
]
}
]
},
{
"line": "Must have maximum age of 75 Years",
"criterions": [
{
"exact_snippets": "maximum age of 75 Years",
"criterion": "age",
"requirements": [
{
"requirement_type": "maximum",
"expected_value": {
"operator": "<=",
"value": 75,
"unit": "Years"
}
}
]
}
]
}
],
"exclusion_lines": [
{
"line": "1. patients with needle phobia;",
"criterions": [
{
"exact_snippets": "patients with needle phobia",
"criterion": "needle phobia",
"requirements": [
{
"requirement_type": "presence",
"expected_value": true
}
]
}
]
},
{
"line": "2. Low platelet count (<50 000); co-morbidity with a bleeding disorder; comorbidity with thyroid dysfunction; pregnancy; haemoglobin levels <10 g/dl and haematocrit <30; anaemia on active pharmacological treatment or receiving blood transfusion or steroids;",
"criterions": [
{
"exact_snippets": "Low platelet count (<50 000)",
"criterion": "platelet count",
"requirements": [
{
"requirement_type": "quantity",
"expected_value": {
"operator": "<",
"value": 50000,
"unit": ""
}
}
]
},
{
"exact_snippets": "co-morbidity with a bleeding disorder",
"criterion": "bleeding disorder",
"requirements": [
{
"requirement_type": "comorbidity",
"expected_value": true
}
]
},
{
"exact_snippets": "comorbidity with thyroid dysfunction",
"criterion": "thyroid dysfunction",
"requirements": [
{
"requirement_type": "comorbidity",
"expected_value": true
}
]
},
{
"exact_snippets": "pregnancy",
"criterion": "pregnancy",
"requirements": [
{
"requirement_type": "presence",
"expected_value": true
}
]
},
{
"exact_snippets": "haemoglobin levels <10 g/dl",
"criterion": "haemoglobin levels",
"requirements": [
{
"requirement_type": "quantity",
"expected_value": {
"operator": "<",
"value": 10,
"unit": "g/dl"
}
}
]
},
{
"exact_snippets": "haematocrit <30",
"criterion": "haematocrit",
"requirements": [
{
"requirement_type": "quantity",
"expected_value": {
"operator": "<",
"value": 30,
"unit": ""
}
}
]
},
{
"exact_snippets": "anaemia on active pharmacological treatment or receiving blood transfusion or steroids",
"criterion": "anaemia",
"requirements": [
{
"requirement_type": "treatment",
"expected_value": [
"active pharmacological treatment",
"receiving blood transfusion",
"receiving steroids"
]
}
]
}
]
},
{
"line": "4. Being pregnant or nursing, or having used acupuncture for peripheral neuropathy within 6 months prior to study entry;",
"criterions": [
{
"exact_snippets": "Being pregnant",
"criterion": "pregnancy",
"requirements": [
{
"requirement_type": "presence",
"expected_value": false
}
]
},
{
"exact_snippets": "nursing",
"criterion": "nursing",
"requirements": [
{
"requirement_type": "presence",
"expected_value": false
}
]
},
{
"exact_snippets": "having used acupuncture for peripheral neuropathy within 6 months prior to study entry",
"criterion": "acupuncture for peripheral neuropathy",
"requirements": [
{
"requirement_type": "usage",
"expected_value": {
"operator": "<=",
"value": 6,
"unit": "months"
}
}
]
}
]
},
{
"line": "5. Life expectancy <6 months;",
"criterions": [
{
"exact_snippets": "Life expectancy <6 months",
"criterion": "life expectancy",
"requirements": [
{
"requirement_type": "duration",
"expected_value": {
"operator": "<",
"value": 6,
"unit": "months"
}
}
]
}
]
},
{
"line": "6. Lymphedema of limbs;",
"criterions": [
{
"exact_snippets": "Lymphedema of limbs",
"criterion": "lymphedema",
"requirements": [
{
"requirement_type": "location",
"expected_value": "limbs"
}
]
}
]
}
],
"miscellaneous_lines": [],
"failed_inclusion": [],
"failed_exclusion": [
{
"line": "3. having metastatic or recurrent disease, history of preexisting peripheral neuropa- thy prior to chemotherapy, uncontrolled seizure disorder, unstable cardiac disease or myocardial infarction within 6 months prior to study entry;",
"criterions": [
{
"exact_snippets": "having metastatic or recurrent disease",
"criterion": "disease status",
"requirements": [
{
"requirement_type": "presence",
"expected_value": [
"metastatic",
"recurrent"
]
}
]
},
{
"exact_snippets": "history of preexisting peripheral neuropathy prior to chemotherapy",
"criterion": "peripheral neuropathy",
"requirements": [
{
"requirement_type": "history",
"expected_value": true
}
]
},
{
"exact_snippets": "uncontrolled seizure disorder",
"criterion": "seizure disorder",
"requirements": [
{
"requirement_type": "control",
"expected_value": "uncontrolled"
}
]
},
{
"exact_snippets": "unstable cardiac disease",
"criterion": "cardiac disease",
"requirements": [
{
"requirement_type": "stability",
"expected_value": "unstable"
}
]
},
{
"exact_snippets": "myocardial infarction within 6 months prior to study entry",
"criterion": "myocardial infarction",
"requirements": [
{
"requirement_type": "time since event",
"expected_value": {
"operator": "<=",
"value": 6,
"unit": "months"
}
}
]
}
]
}
],
"failed_miscellaneous": []
}